↓ Skip to main content

Role of plasma EBV DNA levels in predicting recurrence of nasopharyngeal carcinoma in a western population

Overview of attention for article published in BMC Cancer, May 2012
Altmetric Badge

Citations

dimensions_citation
46 Dimensions

Readers on

mendeley
42 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Role of plasma EBV DNA levels in predicting recurrence of nasopharyngeal carcinoma in a western population
Published in
BMC Cancer, May 2012
DOI 10.1186/1471-2407-12-208
Pubmed ID
Authors

Daris Ferrari, Carla Codecà, Cecilia Bertuzzi, Francesca Broggio, Francesca Crepaldi, Andrea Luciani, Irene Floriani, Mohssen Ansarin, Fausto Chiesa, Daniela Alterio, Paolo Foa

Abstract

Loco-regionally advanced nasopharyngeal carcinomas can be cured by the combination of chemotherapy and radiotherapy. In Eastern countries, plasma levels of viral Epstein-Barr deoxyribonucleic acid (DNA) are accurate in predicting recurrence, but few data are available in Western populations. The aim of this prospective study was to evaluate the relationship between viral Epstein-Barr DNA copy numbers in plasma and the response rate, progression-free survival and overall survival in a cohort of Western patients with stage IIb-IVb nasopharyngeal cancer.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 42 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Poland 1 2%
Unknown 41 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 7 17%
Student > Bachelor 6 14%
Other 5 12%
Researcher 4 10%
Student > Postgraduate 4 10%
Other 9 21%
Unknown 7 17%
Readers by discipline Count As %
Medicine and Dentistry 21 50%
Biochemistry, Genetics and Molecular Biology 3 7%
Nursing and Health Professions 2 5%
Immunology and Microbiology 2 5%
Mathematics 1 2%
Other 5 12%
Unknown 8 19%